CE Unterberg Towbin

Related by string. * ce . Ce . ces . Ces . CEs . CEED . ceed . CES . Ceed . CEER : offi ce . pri ces . sour ces . dans ce . dans ces . Windows Embedded CE . tout ce . CES Unveiled . Monitor CE . achieved CE Marking / Unterberger : Günther Unterberger . Unterberg . CE Unterberg . Richie Unterberger . Christian Unterberger . LF Rothschild Unterberg / : Towbin . Towbin Dodge . Unterberg Towbin * CE Unterberg Towbin Emerging *

Related by context. All words. (Click for frequent words.) 69 CE Unterberg 67 Piper Jaffray 67 ThinkEquity 67 Lazard Capital 67 ThinkEquity Partners LLC 67 Thomas Weisel Partners 67 Kalpesh Kapadia 66 Thomas Weisel 66 SG Cowen 65 WR Hambrecht 65 Lazard Capital Markets 64 Merriman Curhan Ford 64 Leerink Swann 63 Pacific Growth Equities 63 Auriga USA 63 ThinkPanmure 63 Brean Murray 63 Canaccord Genuity 62 Unterberg Towbin 62 Wedbush 62 JMP Securities LLC 62 Keay Nakae 62 Ardour Capital 62 & Renshaw 61 JMP Securities 61 Adams Harkness 61 Brigantine Advisors 61 ThinkEquity Partners 60 Leerink Swan 60 Akhtar Samad 59 WR Hambrecht + 59 Canaccord Adams 59 JoAnne Feeney 59 Kaufman Bros 59 Craig Hallum 59 analyst Shebly Seyrafi 58 Capstone Investments 58 Kaufman Brothers 58 analyst Ajit Pai 58 RBC Capital Markets 58 Stifel Nicolaus 58 Chardan Capital Markets 57 ThinkEquity LLC 57 Feltl 57 Oppenheimer NYSE OPY 57 analyst Greg Mesniaeff 57 analyst Tore Svanberg 57 JP Morgan 57 Satya Chillara 57 analyst Robert Cihra 57 Friedman Billings reiterate 57 Brean Murray Carret 57 Daniel Berenbaum 57 Stifel Nicholas 57 Schwab Soundview 57 analyst Shaul Eyal 57 Rodman Renshaw 57 analyst Liana Moussatos 57 Jonathan Ruykhaver 57 FTN Midwest 56 analyst Patrick Walravens 56 analyst Mark Monane 56 Raj Denhoy 56 Kaufman Bros. 56 Piper Jaffrey 56 Jefferies NYSE JEF 56 Cannacord Genuity 56 analyst Richard Kugele 56 RBC Capital 56 analyst Tim Klasell 56 Leerink 56 Brian Gesuale 56 Cochran Caronia Waller 56 Brigantine Advisors analyst 56 analyst Tim Savageaux 56 Punk Ziegel 56 Cantor Fitzgerald reiterates 56 RW Baird 56 SG Cowen Securities 55 Matthew Kather 55 ThinkPanmure LLC 55 CJS Securities 55 Jefferies 55 ROTH Capital 55 W. Baird 55 Lauren Cooks Levitan 55 Oscar Gruss 55 Nollenberger Capital 55 Betsy Van Hees 55 Jefferies Broadview 55 Piper Jaffray PJC 55 Cochran Caronia 55 MKM Partners LP 55 WR Hambrecht analyst 55 KeyBanc 55 Credit Suisse First 55 www.piperjaffray.com 55 RBC Capital NYSE RY 55 FBR Capital NASDAQ FBCM 55 Piper Jaffray reiterates 55 Gerard Klauer Mattison 55 PiperJaffray 54 Jeffrey Frelick 54 analyst Jeffrey Fidacaro 54 CSFB 54 Jay Srivatsa 54 Wedbush Securities 54 Nicholas Aberle 54 Vijay Rakesh 54 Stifel Nicholaus 54 Joel Sendek 54 Batlivala & 54 LifeTech Capital 54 Caris & 54 Needham Growth Conference 54 Ardour Capital Investments 54 Craig Hallum Capital 54 Nasdaq MERR 54 analyst Amit Hazan 54 Janney Montgomery Scott 54 Janney Montgomery 54 Leerink Swann LLC 54 RBC Capital Mkts Reiterate 54 Needham Growth 53 analyst Raj Denhoy 53 Sidoti & 53 CapStone 53 Arnie Berman 53 Louis Miscioscia 53 Ladenburg Thalmann 53 Analyst Cai von 53 Outperform rating 53 Morgan Joseph TriArtisan 53 Sandler O'Neill Partners LP 53 Broadpoint.AmTech analyst 53 Taglich Brothers 53 JPMorgan Basics 53 BioCentury Future Leaders 53 Sterne Agee 53 RBC Capital Mkts 53 SoundView Technology Group 53 James McIlree 53 Schwab SoundView 53 ANALYST TAKE Stifel Nicolaus 53 Broadpoint 53 Eric Ende 53 Soundview Technology 53 Merriman Curhan 53 ThinkEquity downgraded 53 Friedman Billings 53 Feltl & 53 Panmure Gordon 53 analyst Alex Gauna 53 NASDAQ ARIA 53 analyst Satya Chillara 53 Kaufman Bros reiterate 53 Dr. Jim Birchenough 53 Mark Bacurin 52 SoundView 52 Brion Tanous 52 analyst Edwin Mok 52 JMP Securities downgraded 52 Emkay Research 52 ThinkEquity upgraded 52 Sanganeria 52 Jason Kolbert 52 Daniel Fannon 52 analyst Jonathan Aschoff 52 WR Hambrecht reiterate 52 JP Morgan SMid Cap 52 ROTH Capital Partners 52 Phil Nalbone 52 analyst Jim Reddoch 52 analyst Kristine Koerber 52 BGB Securities 52 MDB Capital Group 52 analyst Ananda Baruah 52 Ramesh Misra 52 Liana Moussatos 52 AmTech 52 RF Micro Device 52 Sidoti Emerging 52 Jason Avilio 52 KeyBanc Capital Markets 52 BMO Capital 52 Ahmar Zaman 52 Fox Pitt Kelton 52 ANALYST TAKE Bear Stearns 52 Rajesh Ghai 52 BWS Financial 52 Broadpoint Gleacher 52 BIO InvestorForum 52 analyst Uche Orji 52 Sanford Bernstein 52 Bancorp Piper Jaffray 52 Credit Suisse 52 Cannacord Adams 52 Nasdaq MOGN 52 analyst William Tanona 52 AVEO Pharmaceuticals 52 Broadpoint Capital 52 Stelios Papadopoulos 52 Suntrust Robinson Humphrey 52 analyst Colby Synesael 52 GARP Research 52 Kash Rangan 52 Wunderlich Securities 52 Richard Fetyko 52 Pancari 52 Fulcrum Global Partners 52 Rachael Rothman 52 Trevor Polischuk 52 analyst Jesse Pichel 52 Healthcare Tailwinds Conference 52 Shemano Group 52 SunTrust Robinson 51 Ananda Baruah 51 Edwin Mok 51 Two Investor Conferences 51 Lead Bookrunning Manager 51 Steven Alexopoulos 51 UBS Warburg 51 Mark Schoenebaum 51 Adam Klauber 51 Randal Konik 51 analyst Glenn Novarro 51 Kaufman Bros. Investor 51 Healthcare Tailwinds 51 Johnson Steichen Kinnard 51 Tenthoff 51 Krishna Shankar 51 Wachovia Capital Markets 51 analyst Mark Lipacis 51 Gary Hsueh 51 Yaron Werber 51 Allan Mishan 51 Jefferies Quarterdeck 51 Todd Koffman 51 Quynh Pham 51 Reiterates Buy rating 51 Piper Jaffray downgrades 51 analyst Louis Miscioscia 51 Prudential Equity 51 Celgene NASDAQ CELG 51 HC Wainwright 51 FBR Capital Upgrades 51 Inc. Nasdaq GLCH 51 Juniper Networks NASDAQ JNPR 51 Michael Masdea 51 ARYx Therapeutics Inc. 51 JMP Securities downgrade 51 FBR Capital Markets 51 Merrill Lynch Tradebot 51 Jay Deahna 51 Joel Fishbein 51 Northland Capital Markets 51 Cormark Securities 51 Barry Tarasoff 51 Friedman Billings Ramsey 51 David Turkaly 51 Novellus Systems 51 Anton Wahlman 51 CapStone Investments 51 Pluristem Therapeutics 51 Sector Outperform 51 Mahesh Sanganeria 51 Y. Edwin Mok 51 Piper Jaffray initiates 51 Tal Liani 51 Ittai Kidron 51 Lazard Capital reiterate 51 Jerry Doctrow 51 Matthew Sheerin 51 Tellabs Presentation 51 Citi Investment 51 analyst Peter Misek 51 analyst Bruce Cranna 51 Keybanc 51 brokerage Sharekhan 51 Sector Perform rating 51 analyst Ittai Kidron 51 Two Upcoming Investor 51 Dahlman Rose 51 ANALYST TAKE JPMorgan 51 Nathan Schneiderman 51 Eric Coldwell 51 Ladenburg Thalmann analyst 51 Glenn Reicin 51 BoA Merrill Lynch 51 Peter Goldmacher 51 voke inc 51 Ajit Pai 51 JMP Securities reiterate 51 Banc 50 Wedbush Morgan 50 analyst Lawrence Keusch 50 ThinkEquity Partners Growth 50 Ventrus Biosciences 50 Hapoalim Securities 50 analyst Gurinder Kalra 50 Doug Sipkin 50 Nasdaq IDIX 50 James NYSE RJF 50 Oppenheimer OPY 50 Boenning & 50 Wedbush Morgan reiterate 50 Dresdner Kleinwort Wasserstein 50 Monane 50 Khandaker Partners 50 Morgan Stanley 50 Anadys Pharmaceuticals 50 Hibernia Southcoast Capital 50 Ladenburg Thalman 50 Finncap 50 Isaac Ro 50 Nasdaq EXAS today 50 AmTech Research 50 Investology 50 Needham Growth Stock 50 CK Cooper 50 Broadpoint Amtech 50 analyst Mehdi Hosseini 50 Ragen Mackenzie 50 Eric Martinuzzi 50 analyst Rommel Dionisio 50 Singular Research 50 analyst Sumit Dhanda 50 analyst Allan Mishan 50 analyst Dinesh Moorjani 50 reaffirmed Outperform rating 50 John DiFucci 50 Evolution Beeson Gregory 50 Wedbush Morgan Securities 50 analyst Walter Piecyk 50 Jason Pflaum 50 Douglas Sipkin 50 Qlik Technologies Inc 50 ANALYST TAKE Jefferies 50 Standpoint Research 50 Glen Yeung 50 SoundView Technology 50 JMP Securities reiterates 50 Natixis Bleichroeder 50 Dhulsini de Zoysa 50 Broadpoint AmTech 50 Sirona Dental 50 Endo Pharmaceuticals NASDAQ ENDP 50 A. Sasa Zorovic 50 Wedbush analyst 50 & Renshaw Techvest 50 Robinson Humphrey 50 Darren Lehrich 50 Paul Mansky 50 Renshaw Techvest 7th 50 Jennifer Fritzsche 50 Inc. Nasdaq MERR 50 KBRO 50 Cyclacel Pharmaceuticals 50 Sherri Scribner 50 Neutral rating 50 Kuni Chen 50 analyst Randall Stanicky 50 firm RHK 50 Merrill Lynch 50 William Tanona 50 Walter Nasdeo 50 Varian Semi 50 James Covello 50 J.P. Morgan Healthcare 50 analyst Erik Suppiger 50 PiperJaffray analyst 50 Piper Jaffray analyst 50 CE Unterberg Towbin Emerging 50 JB Hanauer 50 Brean Murray downgrades 50 analyst Mark Schoenebaum 50 Stuart Muter 50 JPMorgan SMid Cap 50 Putnam Lovell NBF 50 analyst Ken Trbovich 50 ImmunoCellular Therapeutics 50 Lipacis 50 Upcoming Investor Conference 50 JM Dutton 50 Entropic Comms 50 analyst Brad Reback 50 NYSE Amex LTS 50 Richard Kugele 50 Hamed Khorsand 50 analyst Mark Edelstone 49 Inc. NASDAQ MERR 49 Kaufman Bros. LP 49 Gridstone 49 Jeff Fidacaro 49 Auxilium Pharmaceuticals 49 Outperform 49 Market Perform rating 49 Patrick Walravens 49 NASDAQ ERES 49 NASDAQ MOGN 49 Qatalyst Group 49 Deutsche Bank 49 Seattle Genetics SGEN 49 BGC Partners LP 49 Reiterates Hold 49 Ceva Inc 49 Christopher Danely 49 JMP Securities JMP 49 Mark Monane 49 Overweight rating 49 Calyon Securities USA 49 Chris Danely 49 O2Micro International 49 ANALYST TAKE Goldman Sachs 49 Bear Stearns SMid Cap 49 Andrew Garthwaite 49 UBS Investment 49 Piper Jaffray downgraded 49 Reiterates Buy 49 Equity Capital Markets 49 Nasdaq INCY announced 49 Michael Vinciquerra 49 TSRX 49 Thomas Weisel Partners Tech# 49 Freidman Billings Ramsey 49 Peer Perform rating 49 Maintains Outperform 49 Rob Cihra 49 Miller Tabek 49 Allos Therapeutics Incorporated 49 analyst Kemp Dolliver 49 Timothy Arcuri 49 rue# inc 49 Uche Orji 49 JMP Securities Research 49 Maxim Integrated 49 FBR Capital Maintains 49 Bayhill Therapeutics 49 Morgan Keegan reiterate 49 Canaccord 49 TripleTree 49 #th Annual J.P. 49 Geoffrey Meacham 49 Creditsights 49 Jefferies Quarterdeck division 49 Caris 49 Gene Munster Piper Jaffray 49 OrbiMed Advisors 49 Piper Jaffray nyse PJC 49 NYSE PJC 49 analyst Michael Masdea 49 Annabel Samimy 49 analyst Tristan Gerra 49 Sanjiv Wadhwani 49 Small Cap Ideas 49 Putnam Lovell 49 Vishay Intertechnology VSH 49 analyst Amit Bhalla 49 analyst Geoffrey Porges 49 David Hochstim 49 Garo Toomajanian 49 SMART Modular Technologies 49 Nasdaq ANDS 49 DXP Enterprises 49 Novellus Systems Inc 49 Lawrence Keusch 49 Maintains Buy 49 OrbiMed Advisors LLC 49 Piper Jaffray Cos. 49 NASDAQ GPRO 49 Bhavin Shah 49 JP Morgan Securities 49 Denhoy 49 Matt Nemer 49 Suji De Silva 49 analyst Christopher Danely 49 Brean Murray reiterate 49 ANALYST TAKE Merrill Lynch 49 sole bookrunning manager 49 Bert Hazlett 49 BIOCOM Investor Conference 49 Aderis 49 Idenix Pharmaceuticals 49 analyst Arnab Chanda 49 Enam Securities Pvt 49 Adtran Inc 49 Needham Biotechnology 49 Westwind Partners 49 Global Industrials Unplugged 49 BMRN 49 ZIOPHARM Oncology 49 Kevin Vassily 49 Jim Feldhan president 49 Todd Raker 49 Equal Weight rating 49 FBR Capital reiterates 49 Joe Osha 49 SEB Enskilda 49 Maintains Hold 48 OneMedForum San Francisco 48 WestLB Panmure 48 Chris Shibutani 48 Sunesis Pharmaceuticals 48 FTN Equity 48 analyst Dan Wantrobski 48 Joseph Pantginis 48 analyst Maged Shenouda 48 Corporation NASDAQ PRXL 48 #/#/#-Citigroup 48 analyst Geoffrey Meacham 48 Ardea Biosciences 48 Keybanc Capital Markets 48 Robert Cihra 48 BNY Capital Markets 48 analyst Chandan Sarkar 48 Sandler O'Neill 48 JPMorgan 48 Canaccord Adams analyst 48 analyst Tal Liani 48 Sara Michelmore 48 Reiterates Outperform 48 Stanicky 48 Reiterates Neutral Rating 48 Tristan Gerra 48 Analyst Cody Acree 48 ThinkEquity analyst 48 NuVasive NASDAQ NUVA 48 FTN Midwest Securities 48 Resumes Coverage 48 MKM Partners 48 analyst Gbola Amusa 48 analyst Randal Konik 48 J. Steven Smigie 48 UBS Warburg LLC 48 analyst Bijan Moazami 48 Diversified Industrials 48 analyst Ehud Gelblum 48 Volterra Semiconductor 48 Spreadtrum Comms 48 Medica Venture Partners 48 sole bookrunning 48 Zelos Group 48 Dynavax Technologies 48 Reynders Gray 48 GCA Savvian Advisors 48 Canaccord Adams Musculoskeletal 48 Brean Murray upgrades 48 Genelabs Technologies 48 Amy Noblin 48 Stacy Rasgon 48 Zoran ZRAN 48 WR Hambrecht reiterates 48 F5 Networks NASDAQ FFIV 48 Edwin Groshans 48 analyst Joanne Wuensch 48 Nasdaq NPSP 48 ADC Telecommunications Inc 48 Wachovia Securities 48 TriPoint Global Research 48 Mark Edelstone 48 J.P. Morgan SMid Cap 48 SSRX 48 Tore Svanberg 48 analyst Christa Quarles 48 analyst Cody Acree 48 Regeneron Pharma 48 Standpoint Research downgraded 48 Pranjul Bhandari 48 Volterra Semiconductor Corporation 48 NASDAQ CIEN 48 analyst Jonathan Schildkraut 48 Steve Massocca 48 Jesse Pichel 48 Brian Bapty 48 Sandler O'Neill + 48 Rating Reiterated 48 Sandeep Aggarwal 48 Sofinnova Ventures 48 Arbuthnot Securities 48 NASDAQ AUXL 48 Maintains Overweight 48 analyst Budd Bugatch 48 Charles Strauzer 48 Wells Fargo Initiates Coverage 48 Sanjay Shrestha 48 Marc Eiger 48 Inc. Nasdaq ARQL 48 Tad Piper 48 Global Industrials 48 Jefferies JEF 48 KBW 48 Neutral Weight 48 Micros Systems Inc 48 Tao Levy 48 analyst Amit Daryanani 48 Anurag Rana 48 ANALYST TAKE JP Morgan 48 TD Newcrest 48 analyst Sterling Auty 48 orthopedic implant maker 48 Pacific Crest 48 Panmure Gordon analyst 48 Edward Tenthoff 48 Altera NASDAQ ALTR 48 Molowa 48 Trius Therapeutics 48 Ehud Gelblum 48 Evercore Partners EVR 48 Kochnover 48 KRChoksey 48 brokerage Prabhudas Lilladher 48 Ironwood Pharmaceuticals Inc. 48 Aaron Reames 48 Stryker NYSE SYK 48 BancAnalysts Association 48 Reiterates Hold Rating 48 Neely Tamminga 48 Inc. NASDAQ MXIM 48 Sipkin 48 Unterberg 48 Inc. AMEX LTS 48 Kenneth Muth 48 Acumen BioFin Rodman 48 Oncothyreon Inc 48 Pantginis 48 Accuray Incorporated NASDAQ ARAY 48 Cai von Rumohr 48 Xenoport Inc. 48 Inc JEF JEF 48 Altus Pharmaceuticals 48 Helvea SA 48 Piper Jaffray reiterate 48 bookrunning manager 48 http:/www.piperjaffray.com 48 BIO Investor 47 Sycamore Networks SCMR 47 analyst Yaron Werber 47 Northcoast Research 47 Nasdaq ANDS announced 47 Cantel Medical Corp 47 Nasdaq GPRO announced 47 Updata Advisors 47 Moshe Katri 47 LongAcre Partners 47 Jonathan Aschoff 47 NASDAQ ENDP 47 newratings.com Analyst Jonathan Aschoff 47 Canaccord Adams Hepatitis C 47 Aeroflex Holding Corp. 47 ANALYST TAKE Lehman Brothers 47 Broadpoint Gleacher Securities 47 Probitas Partners 47 analyst Vivek Arya 47 Nasdaq BMRN 47 Small Cap Institutional Investor 47 Scott Snyder XPRESSTRADE 47 http:/www.ibb.ubs.com 47 Cepheid NASDAQ CPHD 47 Andrew Vaino 47 Benny Lorenzo 47 Reiterates Buy Rating 47 Rating Maintained 47 Sandler O'Neil 47 Lazard LAZ 47 Inc. Nasdaq IMGN 47 Geoff Porges 47 ThinkEquity initiated 47 Barclays Capital 47 Joseph Teklits 47 analyst Richard Fetyko 47 analyst Katherine Egbert 47 ImmunoGen Inc. 47 CIBC World 47 CEOs Unplugged 47 Seyrafi 47 Mkt Outperform 47 NASDAQ ACOR 47 Jay Vleeschhouwer 47 MLNX 47 OPKO Health 47 Emkay Global 47 Inc. NASDAQ ITMN 47 NLV Partners 47 Gleacher 47 Navdeep Jaikaria 47 Inc. NASDAQ ACUS 47 WR Hambrecht initiates 47 analyst Gil Luria 47 CRNT 47 EarlyBirdCapital Inc. 47 analyst Mahesh Sanganeria 47 Chris Umiastowski 47 Carla Antunes da Silva 47 analyst Sasa Zorovic 47 Sascha Seegan lead 47 analyst Christopher O'Cull 47 William Plovanic 47 Cantor Fitzgerald reiterate 47 Brad Reback 47 IVGN 47 Urigen Pharmaceuticals 47 Intermonte Sim SpA 47 Analyst Dick Bove 47 Dahlman Rose downgraded 47 analyst Emme Kozloff 47 Riverbed Technology Inc 47 MEDACorp 47 CIBC Oppenheimer 47 Romit Shah 47 Natexis Bleichroeder 47 Auriga 47 NuVasive NUVA 47 IDFC SSKI Securities 47 analyst Bruce Harting 47 Migdal Capital Markets 47 Susquehanna Financial 47 Raiffeisen Centrobank 47 Nasdaq IMGN 47 MERIZ 47 Troy Mastin 47 Idenix Pharma 47 Market Perform 47 analyst Hari Sambasivam 47 Robert Lacoursiere 47 FBR Capital Reiterates 47 Nollenberger Capital Partners 47 Schwab SoundView Capital Markets 47 Stifel Nicolaus Cleantech 47 Brent Thill 47 Finisar NASDAQ FNSR 47 analyst Ghansham Panjabi 47 Therapeutic Competitors 47 firm Aite Group 47 Fixed Income Strategist 47 Equinet Institutional Services 47 JMP Securities Healthcare 47 HwangDBS Vickers 47 RW Baird analyst 47 Stifel Nicolaus Weisel 47 Equinet 47 Thoratec Presentation 47 Corporation NASDAQ LRCX 47 Analysts Initiate Coverage 47 Broadpoint.AmTech 47 ABN AMRO Rothschild 47 IPXL 47 FTN Equity Capital Markets 47 EdgeWater Research 47 Rexahn Pharmaceuticals Inc. 47 Tibco TIBX 47 analyst Ashwin Shirvaikar 47 Chordiant Software CHRD 47 Penwest Pharmaceuticals 47 Fifteenth Annual Emerging 47 analyst Anthony Chukumba 47 Vertex Pharmaceuticals NASDAQ VRTX 47 analyst Steven Wieczynski 47 Synta Pharmaceuticals 47 outperformer rating 47 Nasdaq IPXL 47 Religare Capital Markets 47 Ninth Annual JMP 47 analyst Laura Conigliaro 47 RF Micro Devices RFMD 47 Joanna Makris 47 RedChip Small Cap 47 analyst Ari Bensinger 47 Sidoti Micro Cap 47 Underperform rating 47 BioCentury NewsMakers 47 ROTH #nd 47 Sanford C. Bernstein 47 Inc. NASDAQ TWPG 47 Ken Cacciatore 47 Stifel Nicolaus initiates 47 Linear Technology LLTC 47 Dhruv Chopra 47 Growth Institutional Investor 47 Maintains Neutral Rating 47 Eric Kainer 47 Bridgewell Securities 47 Mark Astrachan 47 Advest 47 Monness Crespi Hardt 47 Durect Corporation 47 OMRIX 47 Emerging Growth Equities 47 analyst Nikos Theodosopoulos 47 Group Inc JEF.N 47 analyst Joseph Altobello 47 Nomura Securities 47 Sterne Agree 47 Execution Noble 47 Oppenheimer Industrials 47 Simeonidis 47 analyst Jeff Fidacaro 47 equalweight rating 47 Jason Kantor 47 JSB Partners 47 Instat MDR 47 Deane Dray 47 Assumes Coverage 47 Philip Alling 47 Roopesh Patel 47 Acorda Therapeutics NASDAQ ACOR 47 analyst Douglas Sipkin 47 Quadra Realty Trust 47 NII Holdings NASDAQ NIHD 46 Jed Dorsheimer 46 Shire ADR Reptg 46 UOB KayHian 46 analyst Jeffrey Zekauskas 46 Brean Murray maintains 46 DKR Oasis 46 Nikos Theodosopoulos 46 Sector Performer rating 46 Emerging Growth 46 Natixis Bleichroeder Hidden Gems 46 JPMorgan Cazenove Ltd. 46 analyst Albert Savastano 46 ABN AMRO Incorporated 46 ThinkGreen 46 Keefe Bruyette & 46 Sharekhan 46 Biomarin Pharm 46 Dahlman Rose & 46 COWN 46 Bruce Cranna 46 analyst Jennifer Fritzsche 46 NASDAQ ZIOP 46 Sven Borho partner 46 analyst Srini Pajjuri 46 Tekelec TKLC 46 SIGnificant Investment Options 46 Gary Nachman 46 Clarus Ventures 46 Weisel Partners 46 Carl Christensen XPRESSTRADE 46 Underweight rating 46 Forrester Research NASDAQ FORR 46 AeA Classic Financial 46 Erik Suppiger 46 Oriel Securities Ltd. 46 analyst Hans Mosesmann 46 ViroPharma Incorporated NASDAQ VPHM 46 Idenix Pharmaceuticals Inc 46 Lisnic 46 Ric Prentiss 46 JPMorgan Cazenove 46 Merrill Lynch Smid Cap 46 Broadpoint.Gleacher 46 Drew Brosseau 46 TelecomView 46 Kenneth Zaslow 46 analyst Justin Yagerman 46 KeyBank Capital Markets 46 sole underwriter 46 Josephthal 46 Optimer Pharmaceuticals 46 analyst Simos Simeonidis 46 Taifook Research 46 Bill Shope 46 Conviction Sell 46 Rigel Pharmaceuticals 46 Danely 46 ThinkEquity Growth 46 Jeff Kvaal 46 Angel Stock Broking 46 Marvell Technology NASDAQ MRVL 46 BernsteinResearch 46 Monolithic Power 46 AVNW 46 Needham 46 Nasdaq SLXP 46 D.A. Davidson 46 Seventh Annual JMP 46 AMAG Pharma 46 Westcomb Securities 46 Cowen NASDAQ COWN 46 Tamro Capital 46 Canaccord Genuity Growth 46 Bristol Myers NYSE BMY 46 Inc. Nasdaq COWN 46 analyst Kurt Hallead 46 Inhibitex INHX 46 Intel Corporation INTC.NAS 46 Jason Gurda 46 PRNewswire FirstCall DURECT Corporation 46 Analyst Gene Munster 46 Brean Murray initiates 46 Nasdaq INCY 46 Nasdaq ONXX 46 analyst Moshe Katri 46 analyst Kirk Materne 46 Mark Lipacis 46 ANALYST TAKE SunTrust 46 NASDAQ ALTU 46 Kian Abouhossein 46 Asit C. Mehta 46 Knall Cohen Group 46 analyst Ambrish Srivastava 46 TW Telecom 46 JMP Group 46 Nasdaq FMER 46 Nasdaq ADLR 46 Emisphere Technologies 46 Longbow Research 46 newratings.com Analyst Kurt Hallead 46 NorthPoint Trading Partners 46 Apricus Biosciences 46 Daniel Meron 46 Intermune 46 Dycom Industries 46 Renshaw 9th 46 Mr. Bentsur 46 KJMC 46 SKP Securities 46 Neostem 46 RDEA 46 Nick Spoliar 46 Gilead Sciences NASDAQ GILD 46 FinnCap 46 Goldman Sachs Communacopia XIX 46 Dresdner Kleinwort 46 Bank Degroof analyst 46 Ren Zamora 46 Angel Broking Ltd. 46 Sunesis Pharmaceuticals Inc. 46 NYSE NMR 46 Edelstone 46 Extreme Networks EXTR 46 Robert Spingarn 46 Sushil Finance 46 ENSCO PLC 46 Reiterate Buy rating 46 Nasdaq ELRN 46 Investor Conferences 46 NASDAQ VRTX 46 W. Ruttenbur 46 Umiastowski 46 AR Schmeidler & 46 Rubicon Technology 46 analyst Peter Lisnic 46 BioMimetic Therapeutics NASDAQ BMTI 46 NYSE JEF 46 Upcoming Investor 46 Credit SuisseCredit Suisse 46 Poalim Sahar 46 Leerink analyst 46 Cisco Systems Inc CSCO.NAS 46 analyst Safa Rashtchy 46 Valeant Pharmaceuticals NYSE VRX 46 analyst Bruce Nudell 46 Sanderling Ventures 46 Nasdaq THLD 46 analyst Thomas Filandro 46 Associates VSEA 46 Kaufman Bros. analyst 46 FOXH 46 Sagent Advisors 46 Depomed NASDAQ DEPO 46 Maintained Buy 46 Teradyne TER 46 DnB NOR Markets 46 newratings.com Analyst Andrey Glukhov 46 GenMark Diagnostics 46 Dennean 46 XenoPort NASDAQ XNPT 46 SolarWinds SWI 46 Ben Mogil 46 Masdea 46 Fiduciary Asset Management 46 analyst Ivan Feinseth 46 Semiconductor Specialized industry 46 NAREIT Investor Forum 46 Rajeev Chand 46 Ramon Llamas IDC 46 DA Davidson reiterates 46 George Grofik 46 Joanne Wuensch 46 Bruce Harting 46 Equalweight 46 JM Finn 46 UBS 46 Lauri Brunner 46 Steven Harr 46 Advent Software ADVS 46 Comverge NASDAQ COMV 46 Dylan Cathers 46 NASDAQ IPXL 46 Howe Barnes Hoefer 46 Alnylam Pharma 46 OMRIX Biopharmaceuticals 46 Nick Selvaratnam 46 Barclays Capital Reiterate Overweight 46 CLSA AsiaUSA Forum 46 Oppenheimer 46 Calyon Securities analyst Shebly 46 Keybanc Capital

Back to home page